Images List Premium Download Classic

Inflammatory Disease

Inflammatory Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
The Regents Of The University Of California
September 14, 2017 - N°20170260236

Provided are compositions, including isolated, synthetic or recombinant peptides for: expanding regulatory t cells (treg) populations; for treating or ameliorating a vascular inflammation, and kawasaki disease (kd) or a pediatric acute vasculitis of the coronary arteries, including vascular coronary abnormalities, and acute or chronic vascular inflammatory abnormalities, and methods for making and using them. Provided are immunotherapies for promoting expansion ...
No- and h2s- releasing compounds
Research Foundation Of The City University Of New York
September 14, 2017 - N°20170260124

This disclosure relates to compounds containing both an no-releasing moiety and an h2s-releasing moiety and the use of such compounds in treating inflammatory diseases, including cancers.
Methods, agents and compositions for treatment of inflammatory conditions
Betanien Hospital
September 14, 2017 - N°20170258867

The present invention relates to the screening, diagnosis, prognostic evaluation, and treatment or prevention of age associated inflammation, chronic inflammation, and inflammatory diseases. In particular, the present invention relates to treating or preventing inflammatory diseases (e. G. Rheumatoid arthritis or spondyloarthritis) or patients with inflammatory peripheral gnrh with gnrh antagonists or drugs that lower the effects of gnrh.
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Fatty acid cysteamine conjugates and their use as activators of autophagy
Catabasis Pharmaceuticals, Inc.
September 14, 2017 - N°20170258741

The invention relates to (i) 6-membered heteroaryl substituted fatty acid cystamine conjugates, compositions thereof, methods of treating diseases involving dysregulation of autophagy, such as cystic fibrosis, idiopathic pulmonary fibrosis (ipf), a neurodegenerative disease, inflammatory disease, liver disease, muscle disease, infection and immune disease with this compound, or (ii) a method of treating idiopathic pulmonary fibrosis, mitochondrial diseases, leigh syndrome, diabetes ...
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
Pharmacyclics Llc
September 14, 2017 - N°20170258729

Described herein are pharmaceutical formulations of bruton's tyrosine kinase (btk) inhibitor 1-((r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Also disclosed are methods of using the btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, ...
Compositions and methods of selectively inhibiting irp1 and treating inflammation
Technion Research & Development Foundation Limited
September 07, 2017 - N°20170253881

Compositions and methods of treating an inflammatory disease in a subject are provided. Accordingly there is provided a method comprising administering to the subject a therapeutically effective amount of an agent which selectively inhibits activity and/or expression of iron regulatory protein (irp) 1 and not irp2, thereby treating the inflammatory disease in the subject. Also provided is a pharmaceutical composition ...
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel imidazopyridazine compounds and their use
Hutchison Medipharma Limited
September 07, 2017 - N°20170253618

This disclosure provides novel imidazopyridazine compounds of formula (i) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting pi3k and potential use in treating a disease responsive to inhibition of pi3k, for example, an inflammatory disease, autoimmune disease or cancer.
Kinase inhibitors
Hutchison Medipharma Limited
September 07, 2017 - N°20170253563

Wherein r1a to r1e, r2 to r4, r5a, l and x1 to x3 have meanings given in the description, which compounds have antiinflammatory activity, for example through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; syk kinase; and members of the src family of tyrosine kinases) and have use ...
Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate ...
Arc Medical Devices, Inc.
September 07, 2017 - N°20170252367

Compositions and methods involving administration of agents useful for the treatment, prevention, inhibition, etc., of inflammatory disease or fibrous adhesions using low sulphate fucans and, if desired, one or more other anti-inflammatory disease or anti-fibrous adhesion agent.
Method and compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and ...
Ose Immunotherapeutics
August 31, 2017 - N°20170247464

The present invention pertains to the field of immunoterapy. More specifically, the present invention provides a method for differentiating myeloid-derived suppressor cells (mdsc) into non suppressive cells, by administering a compound blocking the interaction between sirpa and cd47 to a patient in need thereof in order to reduce mdsc-induced immunodepression and consequently allow appropriate immune responses in cancers, infectious diseases, ...
Use of anti-eotaxin antibodies for treating inflammatory bowel disease
Immune Pharmaceuticals Ltd.
August 31, 2017 - N°20170247442

The present invention provides use of one or more complementary determining regions (cdrs) of the cat-212-213 vh and/or vl domains in non-native antibody framework regions, or, alternatively, the whole vh, vl, or cat-212 antibody, in treating inflammatory diseases in a subject, such as inflammatory bowel disease.
Conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy
Biolitec Unternehmensbeteiligungs Ii Ag
August 31, 2017 - N°20170247384

Biologically active compounds that can be used as photosensitizers for diagnostic and therapeutic applications, particularly for pdt of cancer, infections and other hyperproliferative diseases, fluorescence diagnosis and pdt treatment of a non-tumorous indication such as arthritis, inflammatory diseases, viral or bacterial infections, dermatological, ophthalmological or urological disorders are provided as well as providing methods to obtain them in pharmaceutical quality. ...
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
The Regents Of The University Of Michigan
August 31, 2017 - N°20170246294

The present invention provides methods and compositions for the stimulation of immune responses and for treating or preventing allergic disease and responses and inflammatory disease and responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses that prevent or treat allergic disease by reducing allergic response. Compositions and methods ...
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate ...
Arc Medical Devices, Inc.
August 31, 2017 - N°20170246202

Compositions and methods involving administration of agents useful for the treatment, prevention, inhibition, etc., of inflammatory disease or fibrous adhesions using low sulphate fucans and, if desired, one or more other anti-inflammatory disease or anti-fibrous adhesion agent.
Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
Oliventures, Inc.
August 31, 2017 - N°20170246136

The present invention relates to cancer therapy by administering a specific dietary compensation. Especially the invention relates to a pharmaceutical, medical food or dietary supplement composition comprising the combination of the following three active ingredients: hydroxytyrosol, fish oil epa/dha and curcumin. The pharmaceutical composition is useful in the treatment or prevention of cancer, especially breast cancer.
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of ...
Yeda Research And Development Co. Ltd
August 24, 2017 - N°20170240634

A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the cns that does not include the autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (rrms), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two ...
Antibody therapeutics that bind ctla4
Sorrento Therapeutics, Inc.
August 17, 2017 - N°20170233476

There is disclosed compositions and methods relating to or derived from anti-ctla4 antibodies. More specifically, there is disclosed fully human antibodies that bind ctla4, ctla4-antibody binding fragments and derivatives of such antibodies, and ctla4-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, ...
Methods and compositions for t cell generation and uses thereof
California Institute Of Technology
August 17, 2017 - N°20170232092

Among the various aspects of the present disclosure is the provision of a method of treating an inflammatory bowel disease. Another aspect provides the provision of a screening method for therapeutic agents. Another aspect provides a method of detecting treg cells to determine if a subject has an inflammatory disease. The present disclosure provides for methods of treatment, diagnosis, and ...
Treatment of ocular inflammatory diseases using laquinimod
Teva Pharmaceutical Industries, Ltd.
August 17, 2017 - N°20170231971

Disclosed is a method for treating an ocular inflammatory disease (oid), e. G., uveitis or conjunctivitis, comprising periodic administration of a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt thereof. Also provided is a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for use in treating a subject suffering from an oid, uveitis, bacterial conjunctivitis, viral ...
Supporting immunomodulatory agent
Flexopharm Brain Gmbh & Co. Kg
August 17, 2017 - N°20170231933

The invention relates to an agent supporting the immunomodularity for the treatment of autoimmune diseases, said agent containing c3-c8 carboxylic acids, their physiologically tolerable salts and/or esters with c1-c8 alkyl alcohols, their use as supporting immunomodulators for autoimmune related diseases and immune-mediated chronic inflammatory diseases, as well as dietary supplements with immunomodulating effect containing these.
Anti-orai1 antibody
Daiichi Sankyo Company, Limited
August 10, 2017 - N°20170226203

It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human orai1 and has the activity of inhibiting human t cell activation.
Loading